Filtered By:
Procedure: Baloon Angioplasty

This page shows you your search results in order of date. This is page number 12.

Order by Relevance | Date

Total 319 results found since Jan 2013.

Thirty-Day and One-Year Outcomes of Endovascular Treatments for Severe Atherosclerotic Stenosis of Intracranial ICA: Results From a Single Center
Conclusions: Both the 30-day and 1-year outcomes of tailored endovascular treatments seemed to be acceptable in the treatment of symptomatic atherosclerotic stenosis of the intracranial ICA. However, this needs to be confirmed by further investigation, preferably in large multicenter randomized controlled clinical trials.
Source: Frontiers in Neurology - May 25, 2021 Category: Neurology Source Type: research

Utilization of the Ballast Long Guiding Sheath for Neuroendovascular Procedures: Institutional Experience in 68 Cases
Conclusions: We demonstrate the feasibility of the Ballast long guiding sheath to successfully deliver modern neurointerventional treatment devices through tortuous anatomy.
Source: Frontiers in Neurology - May 7, 2021 Category: Neurology Source Type: research

Bridging Therapy for Acute Stroke as the Initial Manifestation of Takayasu Arteritis: A Case Report and Review of Literature
We report a rare case of a patient with TA initially presenting with AIS treated with bridging therapy with full recovery of neurological function. Bridging therapy should be taken into consideration for AIS in patients with TA. Further study is needed in this regard.
Source: Frontiers in Immunology - April 30, 2021 Category: Allergy & Immunology Source Type: research

Safety and Efficacy of Tirofiban for Acute Ischemic Stroke Patients With Large Artery Atherosclerosis Stroke Etiology Undergoing Endovascular Therapy
Conclusions: Tirofiban in AIS patients with LAA undergoing EVT is safe and may benefit the functional outcomes in anterior circulation and major stroke patients and showed a trend for reduced mortality.
Source: Frontiers in Neurology - February 11, 2021 Category: Neurology Source Type: research

Chimney Endovascular Aneurysm Repair From Below is Attractive but Carries the Risk of a Relevant Complication
For the placement of chimney grafts, upper extremity access is necessary however, not all patients have suitable aortic arch anatomy, and it also carries a risk of stroke. In this context, successful chimney endovascular aneurysm repair (ChEVAR) via femoral access is attractive. Seven years ago, we presented the lift technique, which we used in 13 patients, placing self expanding covered stents approximately 1 –2 cm into the target renal artery from below. After fixation of the distal end with an angioplasty balloon, an 8 F sheath was carefully pushed over a stiff guidewire, lifting the chimney endograft upwards.
Source: European Journal of Vascular and Endovascular Surgery - December 3, 2020 Category: Surgery Authors: Konstantinos P. Donas, Gergana T. Taneva Tags: Letter to the Editor Source Type: research

Evaluation of mortality following paclitaxel drug-coated balloon angioplasty of femoropopliteal lesions in patients with ulcerations and gangrene - a single center experience.
Conclusions: This monocentric retrospective analysis showed no survival disadvantage for patients in Rutherford-Becker stage 5 after treatment with paclitaxel-coated balloons. PMID: 33118425 [PubMed - as supplied by publisher]
Source: VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases - October 29, 2020 Category: Surgery Authors: Böhme T, Noory E, Beschorner U, Jacques B, Bürgelin K, Macharzina R, Kuhn LM, Nührenberg T, Neumann FJ, Zeller T Tags: Vasa Source Type: research

Atherectomy with balloon angioplasty compared to balloon angioplasty alone for the treatment of chronic limb threatening ischemia: A national surgical quality improvement program database analysis.
CONCLUSION: Atherectomy with balloon angioplasty of femoropopliteal disease provides a significant decrease in untreated loss of patency compared to balloon angioplasty alone. PMID: 33045944 [PubMed - in process]
Source: Vascular - October 16, 2020 Category: Surgery Authors: Lam A, Schwertner A, Katrivesis J, Fernando D, Nelson K, Abi-Jaoudeh N Tags: Vascular Source Type: research

What Are the Main Acyanotic Congenital Heart Diseases?
Discussion Congenital heart diseases (CHD) are malformations of the heart and great vessels. It occurs in about 5-8/1000 live births. Cyanotic congenital heart disease is often noted perinatally because of cyanosis, respiratory distress and/or poor feeding or other distress type problems. A review can be found here. Acyanotic congenital heart disease (ACHD) can present at birth but often is seen in older children or adults unless the lesions are severe, especially obstructive lesions. Severe lesions may also cause cyanosis and distress type problems in patients also. Shunting lesions cause problems by diverting blood flo...
Source: PediatricEducation.org - August 17, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Endovascular therapy versus medical treatment for symptomatic intracranial artery stenosis.
CONCLUSIONS: This systematic review provides moderate-quality evidence showing that ET, compared with CMT, in people with recent symptomatic severe intracranial atherosclerotic stenosis probably does not prevent recurrent stroke and appears to carry an increased hazard. The impact of delayed ET intervention (more than three weeks after a qualifying event) is unclear and may warrant further study. PMID: 32789891 [PubMed - in process]
Source: Cochrane Database of Systematic Reviews - August 10, 2020 Category: General Medicine Authors: Wang T, Luo J, Wang X, Yang K, Jadhav V, Gao P, Ma Y, Zhao N, Jiao L Tags: Cochrane Database Syst Rev Source Type: research

Feasibility and Safety of Paclitaxel-Coated Balloon Angioplasty for the Treatment of Intracranial Symptomatic In-Stent Restenosis
Conclusion: This preliminary study indicates that PCB angioplasty is feasible and safe for the treatment of intracranial sISR. Further studies are needed to clarify its efficiency and long-term outcome.
Source: Frontiers in Neurology - August 10, 2020 Category: Neurology Source Type: research

Leave Nothing Behind: Treatment of Intracranial Atherosclerotic Disease with Drug-Coated Balloon Angioplasty
ConclusionIn this study, the application of DCBs to treat ICAD patients was feasible and safe. A  larger scale clinical trial is warranted to further evaluate the safety and efficacy of this treatment.
Source: Klinische Neuroradiologie - July 26, 2020 Category: Radiology Source Type: research

Drug-Coated Balloon Treatment in Symptomatic Intracranial High Grade Stenosis
ConclusionThis DCB-PTA cohort study showed a  relatively low intracranial complication rate of 6% with a symptomatic recurrence rate of 12%. Larger trials are needed to validate these promising observations.
Source: Clinical Neuroradiology - July 19, 2020 Category: Neurology Source Type: research

COVID-19 and Stroke: Casual or Causal Role?
We present a case of stroke in a 62-year-old COVID-19-positive patient, with multiple vascular risk factors. The patient arrived 1 h after onset of symptoms, was treated with recombinant tissue plasminogen activator (rtPA) with improvement of neurologic deficits, and later developed right foot arterial ischemia (recanalized by balloon catheter angioplasty) and left arm superficial venous thrombosis. A control computed tomography (CT) scan 7 days after onset showed hemorrhagic transformation of ischemic lesion without mass effect. However, respiratory and neurologic conditions improved so that the patient was discharged to ...
Source: Cerebrovascular Diseases - July 7, 2020 Category: Neurology Source Type: research

Transcranial duplex ultrasound monitoring of intracranial arterial stenosis treated with ELUTAX "3" drug-eluting balloon.
We report the results of transcranial ultrasound monitoring in three patients with intracranial arterial stenosis of the middle cerebral artery treated with the only drug-eluting balloon certificated for intracranial use in highly symptomatic intracranial arterial stenosis, ELUTAX "3" (AR Baltic Medical). We performed transcranial Doppler ultrasounds 24 h, 72 h, 10 days, 15 days and 30 days after the angioplasty, thereby measuring mean flow velocity (MFV) in the maximum stenosis area in patients with symptomatic steno-occlusive disease of the middle cerebral artery treated with ELUTAX "3". Two patients were treated during ...
Source: Interventional Neuroradiology - June 2, 2020 Category: Radiology Tags: Interv Neuroradiol Source Type: research

Treatment Strategies for Tandem Occlusions in Acute Ischemic Stroke
Semin intervent Radiol 2020; 37: 207-213 DOI: 10.1055/s-0040-1709207There is no consensus for the treatment of a tandem occlusion (TO) in a patient presenting with an acute ischemic stroke. In this review article, we will focus on the controversial treatment strategies for TOs. First, we will discuss treatment options including retrograde, antegrade, and delayed approaches. Second, the role of carotid stent placement versus balloon angioplasty for the extracranial occlusion will be presented. Third, anticoagulation and antiplatelet regimens for the treatment TOs published in the literature will be reviewed. Finally, we wil...
Source: Seminars in Interventional Radiology - May 13, 2020 Category: Radiology Authors: Gemmete, Joseph J. Wilseck, Zachary Pandey, Aditya S. Chaudhary, Neeraj Tags: Review Article Source Type: research